Lantern Pharma Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LTRN | PCSA | CLRB | TPST | APLM | HBP.TO | |
|---|---|---|---|---|---|---|
| Market cap | 8.76M | 5.41M | 11.63M | 9.26M | 55.38M | 70.27M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.3 | -0.5 | -0.6 | -0.4 | -29.2 | -8.4 |
| Price/book | -2.3 | -17.0 | 0.3 | -6.8 | -12.8 | 4.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −83.04% | −77.18% | −60.78% | −95.29% | +71.38% | −54.68% |
| Today | −2.61% | −0.26% | −6.11% | −1.13% | −8.83% | 0.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All LTRN news ›Empery Asset Management, LP Trims Lantern Pharma Inc (LTRN) Stake by 10.30%
Empery Asset Management, LP Trims Lantern Pharma Inc (LTRN) Stak GuruFocus Empery Asset Management, LP Trims Lantern Pharma Inc (LTRN) Stake by 10.30% Transaction Overview: A Strategic Reduction in LTRN Holdings On September 30, 2026,…
Lantern Pharma secures Taiwan clearances for Phase II NSCLC study
Lantern Pharma has secured regulatory and Institutional Review Board (IRB) clearances in Taiwan to initiate Part 2 of its Phase II HARMONIC clinical trial of LP-300 in combination with carboplatin and pemetrexed in never-smokers with…
Lantern Pharma Receives Taiwan Approvals to Open Next Stage of Phase 2 HARMONIC™ Trial of LP-300 in Never-Smoker, EGFR-Mutant NSCLC
In the United States, a central IRB has approved the amended protocol, and academic clinical sites have begun identifying patients whose tumors carry the EGFR exon 21 L858R mutation. Patients enrolled under the amended protocol will be…
Lantern Pharma Closes $4 Million Registered Direct Offering to Advance AI-Driven Oncology Pipeline
citybuzz - Lantern Pharma (NASDAQ: LTRN), a clinical-stage, AI-native biopharma company that uses artificial intelligence and genomic data to develop precision oncology therapies, announced the closing
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- citybuzz.co1
- gurufocus.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.